IVD Medical Holding (HKSE:01931) Change In Working Capital : HK$0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is IVD Medical Holding Change In Working Capital?

IVD Medical Holding's change in working capital for the quarter that ended in Dec. 2023 was HK$0 Mil.

IVD Medical Holding's change in working capital for the fiscal year that ended in Dec. 2023 was HK$-38 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

IVD Medical Holding Change In Working Capital Historical Data

The historical data trend for IVD Medical Holding's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IVD Medical Holding Change In Working Capital Chart

IVD Medical Holding Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Working Capital

Get a 7-Day Free Trial

146.51

-18.08

-153.23

-67.57

-37.94

IVD Medical Holding Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Working Capital	Get a 7-Day Free Trial									-	-	-	-	-

IVD Medical Holding Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

IVD Medical Holding Change In Working Capital Related Terms

Thank you for viewing the detailed overview of IVD Medical Holding's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

IVD Medical Holding (HKSE:01931) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » IVD Medical Holding Ltd (HKSE:01931) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 299, Bisheng Road, Room 602, Building 6, Zhangjiang Hi-Tech Park, Pudong New Area District, Shanghai, CHN

Website

http://www.ivdholding.com

IVD Medical Holding Ltd is principally engaged in the sale and manufacture of medical equipment and consumables and the provision of consultancy and maintenance services related to medical equipment. It has three segments. The distribution business, which is the key revenue driver, involves the trading of IVD analysers, reagents, and other consumables to customers such as distributors, hospitals and healthcare institutions, and logistics providers. The After-sales Services provided by Vastec include maintenance and repair services, installation services and end-customer training. Its Self-branded Products Business, distributes its self-developed IVD products under its own brand which includes IVD analysers and reagents under the IVD testing category of Point-of-care testing.

Executives

Leung King Sun
Wu Meizhen	2201 Interest of corporation controlled by you
China International Trust Limited	2201 Interest of corporation controlled by you
Wu Yanfeng	2201 Interest of corporation controlled by you
Wu Mingcong	2201 Interest of corporation controlled by you
Wu Junfeng	2201 Interest of corporation controlled by you
Shen Li	2201 Interest of corporation controlled by you
Nd Medical Technology Limited	2201 Interest of corporation controlled by you
Ma Zhouwei	2201 Interest of corporation controlled by you
Hong Kong Medicine Group Limited	2201 Interest of corporation controlled by you
Hknd Gene Biotechnology Limited	2201 Interest of corporation controlled by you
Fast Benefit Pharmaceutical Limited	2201 Interest of corporation controlled by you
China Smart Pharmaceutical Technology Limited	2201 Interest of corporation controlled by you
3w.com Holding Limited	2201 Interest of corporation controlled by you
Morgan Stanley	2201 Interest of corporation controlled by you

IVD Medical Holding (HKSE:01931) Headlines

No Headlines